Semler Scientific, Inc.

UNDERVALUEDSMLR · NASDAQ · Healthcare
SMLR·NASDAQ·Healthcare
UNDERVALUED
Semler Scientific, Inc.
15.9%upside
MARKET PRICE
$21.00
FAIR PRICE
$24.33
MARGIN
$3.33
UNDERVALUEDFAIROVERVALUED
P/E RATIO
6.4x
DIV. YIELD
N/A
ROE
15.6%
MARKET CAP
$270M
FPI
fairpriceindex.com

FAIR PRICE VALUATION

15.9%upside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$21.00

FAIR PRICE

$24.33

MARGIN

$3.33

UNDERVALUEDFAIROVERVALUED

P/E Ratio

6.4x

What is P/E? →

Div. Yield

N/A

ROE

15.6%

Strong

Market Cap

$270M

Small-cap

NOW AVAILABLE

Get notified when SMLR's fair price changes

Push notifications when SMLR's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

4.3/ 10

Attractive valuation and low debt levels, but below-average fundamental quality.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$19.46CONSERVATIVE ENTRY
$24.33FAIR PRICE
$21.00MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$19.46

Fair price × 0.80

DISTANCE

7.3%

Price to entry level

At the current price of $21.00, SMLR trades 7.3% above the conservative entry level of $19.46. This entry level represents a 20% margin of safety below the calculated fair price of $24.33 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate SMLR's fair price

Semler Scientific, Inc.'s fair price of $24.33 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $21.00, SMLR trades 15.9% below its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting SMLR's risk profile.

RELATIVE · 30%

Comparing SMLR's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for SMLR, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate SMLR's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for SMLR.

Explore on Bulios

FAQ

What is the fair price of SMLR?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Semler Scientific, Inc. is $24.33. At the current market price of $21.00, SMLR trades 15.9% below its calculated fair value.

Is SMLR overvalued or undervalued?+

Semler Scientific, Inc. is currently undervalued based on our valuation model. The stock trades at $21.00, which is 15.9% below the fair price of $24.33. The P/E ratio of 6.4x is a key metric in the valuation.

What is the margin of safety for SMLR?+

With a 20% margin of safety applied to the fair price of $24.33, the conservative entry level for SMLR is $19.46. At the current market price of $21.00, the stock trades 7.3% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is SMLR's fair price updated?+

We update fair price calculations for SMLR daily after market close. The current fair price of $24.33 incorporates the latest market data and sector multiples.

What factors affect SMLR's fair price calculation?+

SMLR's fair price of $24.33 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 6.4x, ROE of 15.6%.

Is SMLR a good buy right now?+

At $21.00, SMLR trades 15.9% below our fair value estimate of $24.33. The stock is currently undervalued. ROE stands at 15.6% (strong). Fair Price Index provides valuation data — always do your own research before investing.

Does SMLR pay dividends?+

SMLR does not currently pay a dividend.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.